Background: Detecting a more advanced stage of the primary melanoma after wide local excision and reconstruction can complicate patient counseling about prognosis, management of surgical margins, and indications for sentinel lymph node biopsy.
W
hen residual melanoma remains after the diagnostic biopsy, upstaging (defined as an increase in the T stage designated by the American Joint Committee on Cancer [AJCC] classification system for melanoma) 1 might be detected after wide local excision in 5%-22% of cases. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Upstaging might complicate patient counseling about prognosis and surgical management of melanoma.
AJCC tumor stage is a powerful predictor of prognosis, with 10-year survival ranging from 93% for T1a melanoma to 39% for T4b melanoma. 1 Patients who are counseled about an excellent prognosis before surgery might be surprised and confused to learn of a worse prognosis if the tumor upstages after a wide local excision.
Surgical management might also be complicated by upstaging because the Breslow depth, ulceration status, and mitotic rate from the diagnostic biopsy of a primary cutaneous melanoma dictate the surgical excision margins and the indications for sentinel lymph node biopsy (SLNB). 12 First, if an inaccurate diagnostic biopsy leads to undertreatment with narrower surgical margins than those recommended by consensus guidelines, patients might need additional surgery either to clear the tumor or to comply with wider margins recommended for the upstaged tumor. Neither the randomized trials that inform guidelines for surgical management of primary cutaneous melanoma nor consensus guidelines address surgical margins after upstaging. [12] [13] [14] [15] [16] [17] [18] Second, 1.3%-10% of upstaged tumors will meet criteria for SLNB. 2, 5, 6, 11 While some case series have demonstrated that SLNB can be performed after reconstruction, especially after linear repairs, with good sensitivity and rare false negatives, [19] [20] [21] the accuracy of SLNB after flap and graft reconstruction remains uncertain. 12, 22, 23 Clarifying risk factors for upstaging is important to help clinicians improve preoperative counseling about prognosis and surgical management, particularly when deciding whether or not to delay reconstruction for final staging of the wide local excision specimen. 6 Current data about upstaging must often be gleaned from reports that focus primarily on surgical technique 2-4,6-9 or biopsy method. 11, [24] [25] [26] [27] Factors other than surgical technique and biopsy method might independently increase the risk for upstaging. One previous study correlated microstaging accuracy with biopsy method as well as several other clinicopathologic factors. 27 Compared with excisional biopsy, punch and shave biopsy had a significantly increased risk for inaccurate microstaging. 27 Among partially biopsied lesions, tumor thickness (increased risk for thicker tumors) was the only clinicopathologic factor that significantly affected microstaging accuracy after multivariate analysis. However, these results might not be generalizable because excision was the method of biopsy in a high percentage (78.6%) of the cohort. Nonexcisional biopsy methods (shave, punch, or incisional) to diagnose melanoma are more common than excisional biopsy in many patient populations 24, 26, 28 and have been noted to increase the risk for inaccurate microstaging. 11, 27 This study adds to the work of previous authors by examining the impact on upstaging of the widest reported array of clinicopathologic risk factors in a large cohort of melanomas diagnosed with a blend of excisional and nonexcisional preoperative biopsies, which might be more generalizable to many patient populations. 24, 26 The principal aims of this study were to describe the rate of upstaging after wide local excision of cutaneous melanoma and to evaluate clinical and pathologic risk factors associated with upstaging. Secondarily, we aimed to describe how frequently consensus recommendations for surgical management differ for discrepant tumor stages before and after wide local excision.
METHODS

Experimental design
This retrospective cross-sectional study was approved by the institutional review board at the Hospital of the University of Pennsylvania. Inclusion criteria for this study were age $18 years, pathologic T stage on diagnostic biopsy of in situ to T4a (T4b were excluded because they have no risk for upstaging), biopsy-proven melanoma whose diagnostic biopsy and excision specimens were interpreted by a board-certified dermatopathologist at the University of Pennsylvania from January 1, 2008, through December 31, 2013, and initial treatment with conventional wide local excision by a University of Pennsylvania Health System provider. Wide local excision was defined as excision of a biopsy-proven melanoma with a margin of clinically normal skin and immediate reconstruction, followed by microscopic margin assessment via formalin-fixed, paraffin-embedded bread loaf tissue sections. Eligible cases were identified via a search of the Dermatopathology database for ''melanoma'' and ''lentigo maligna'' (LM), which resulted in the identification of 7657 pathology reports containing either term in the line diagnosis. Review of the medical record identified 1332 melanomas that met inclusion criteria for this study. The possibility of upstaging should be considered during patient counseling and surgical planning.
included in the study accounted for 2 (1 pathology report for the diagnostic biopsy and 1 for the wide local excision) of the 7657 reports. In addition, some melanomas had multiple preoperative biopsies and some pathology reports were from re-excisions for positive or equivocal margins. Most remaining cases were excluded because either the diagnostic biopsy or the wide local excision specimen was interpreted by a physician outside of the Penn health system. No a priori study size calculation was performed to determine the desired sample size.
Data collection
All data were recorded in a de-identified fashion in a RedCap database before statistical analysis.
After verifying patient eligibility for this study, clinical notes and pathology reports from the diagnostic biopsies and wide local excisions for each patient were reviewed. The following data were recorded from the clinical notes and pathology reports: biopsy method, anatomic location, patient age at biopsy, personal history of melanoma, prior history of treatment, and histopathologic characteristics of the melanoma (presence or absence of residual melanoma in the excision specimen, invasive versus in situ disease, Breslow depth, mitotic rate, ulceration, regression, LM subtype versus other subtypes). If multiple pre-excision scouting biopsies had been performed, the number of scouting biopsies was recorded, and the tumor was classified according to the most advanced tumor stage.
Data analysis
Each case of melanoma was assessed for the presence of upstaging (defined as an increase in the T stage in the AJCC classification system for melanoma) 1 after histopathologic evaluation of the wide local excision specimen. The frequency of upstaging was correlated with patient demographic characteristics, history of prior treatment, anatomic location (trunk and proximal extremities vs head, neck, hands, feet, genitals [including the nipple and areola], and pretibial leg), histopathologic characteristics of the melanoma (regression, ulceration, invasive vs in situ disease, and LM histologic subtype vs other subtypes), biopsy method (excisional vs other), and biopsy specimen margin positivity (lateral or deep) as assessed by histopathology. Anatomic locations were classified according to consensus guidelines for appropriate use criteria (AUC) of Mohs micrographic surgery: AUC-appropriate (head, neck, acral sites, genitalia [including nipple and areola], and pretibial leg) versus AUC-uncertain (trunk and proximal extremities). 29 Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Univariate logistic regression was used to identify potential risk factors for upstaging. Multivariate stepwise logistic regression with a prespecified cut off value of P $ .200 was then performed to reduce confounding. With each iteration of the stepwise regression analysis, the risk factor with the highest P value was sequentially removed from the multivariate model until no variables remained with a P value $ .200. All data analyses were performed using STATA version 13 (StataCorp, College Station, Texas). Table I shows the demographic and clinicopathologic features of the melanomas included in this study.
RESULTS
Residual tumor and upstaging
Upstaging was observed in 3.9% (52/1332) of melanomas overall and in 11.3% (52/460) of lesions with residual microscopic melanoma (in situ or invasive) in the wide local excision specimen. Residual invasive melanoma was seen in 12.8% (170/1332) of wide local excision specimens. Of these, 49% (83/170) had a deeper Breslow depth than the pre-excision diagnostic biopsies.
Risk factors that were significantly associated with an increased risk for upstaging after multivariate analysis included anatomic location on the head, neck, hands, feet, genitals, or pretibial leg; multiple preoperative diagnostic biopsies; extension of melanoma to the base of the diagnostic biopsy; increasing patient age; and non-LM histopathologic subtype (Table II) . Raw frequencies for upstaging were 12% (5/41) on the hands or feet and 12% (25/207) on the head or neck. Prior treatment and extension to the lateral margin of the diagnostic biopsy specimen were associated with an increased frequency of upstaging on univariate analysis but failed to remain significant predictors of upstaging after multivariate analysis. Statistically significant differences in rates of upstaging were not associated with excisional versus nonexcisional biopsy, sex, personal history of melanoma, regression, or in situ versus invasive disease.
Specific changes in pathologic T staging that resulted in upstaging are shown in Table III . Of the melanomas with upstaging, 21% (11/52) became candidates for SLNB. Three additional melanomas did not change T stage but qualified for SLNB because of an increase in Breslow depth from \0.76 mm to 0.76-1 mm. Thus, of the 1019 melanomas with a Breslow depth of #0.75 mm noted on the diagnostic biopsy, 1.4% (14/1019) became candidates for SLNB. Of these 14 melanomas, 64% (9/14) were on the head, neck, hands, feet, genitals, or pretibial leg; 79% (11/14) had melanoma extending to the base of the diagnostic biopsy; 93% (13/14) had melanoma extending to the lateral margin of the diagnostic biopsy; and 29% (4/14) had multiple preoperative scouting biopsies.
Of the melanomas with upstaging, 62% (32/52) had a T stage that warranted wider surgical margins than those recommended for the pre-excision tumor stage. Thus, of the 1246 in situ or stage T1 or T2 invasive melanomas, 2.6% (32/1246) upstaged to a T stage that warranted wider surgical margins than those recommended for the pre-excision tumor stage. For these 32 melanomas, 56% (18/32) were on the head, neck, hands, feet, genitals, or pretibial leg; 59% (20/32) had melanoma extending to the base of the diagnostic biopsy; 91% (29/32) had melanoma extending to the lateral margin of the diagnostic biopsy; and 19% (6/32) were biopsied with multiple scouting biopsies.
DISCUSSION
This study evaluated 1332 melanomas treated with wide local excision to correlate the risk for upstaging with the largest reported array of clinicopathologic risk factors. Compared with the diagnostic biopsies, wide local excision specimens were more likely to contain a higher tumor stage when cutaneous melanomas had the following independent risk factors: anatomic location on the head, neck, hands, feet, genitals, or pretibial leg; multiple preoperative diagnostic biopsies; extension of melanoma to the base of the diagnostic biopsy; increasing patient age; and non-LM histopathologic subtype. These findings are helpful to guide preoperative prognostic counseling and surgical management of melanoma.
Despite National Comprehensive Cancer Network guidelines recommending narrow excision with 1-3 mm margins as the preferred method to biopsy lesions suspicious for melanoma, 12 only 10% of cases in our cohort had a preoperative excisional diagnostic biopsy. This low rate of excisional biopsies is consistent with previously published cohorts. 24, 26 Biopsy method (ie, excision versus nonexcision) was not significantly associated with an increased frequency of upstaging in our cohort (P = .068, 95% CI 0.87-51.7). However, extension of the melanoma to the base of the biopsy and multiple diagnostic scouting biopsies, factors that indicated a subtotal biopsy, were significant predictors of an increased risk for upstaging after multivariate analysis. Extension of melanoma to the lateral aspect of the pre-excision biopsy specimen was a significant predictor in univariate analysis, but it failed to remain a significant predictor after multivariate analysis, possibly because of confounding with these other markers of subtotal biopsies. Our data indicate that subtotal biopsy, regardless of the biopsy method or number of scouting biopsies, has an increased risk for upstaging. This finding is consistent with prior studies that showed a correlation between partial sampling of a lesion and higher rates of upstaging. 11, 27 Anatomic location on the head, neck, hands, feet, genitals, or pretibial leg was the strongest predictor of upstaging (OR 7.06, 95% CI 3.77-13.25). A logical supposition might be that the more than 7-fold increased odds of upstaging occurred because excisional biopsies were less common or less practical in these locations, excisional biopsy was actually slightly more prevalent (11%, 31/278) on the head, neck, hands, feet, genitals, or pretibial leg than on the trunk and proximal extremities (9.7%, 103/1067) in our cohort. However, excisional biopsies were less likely to have negative margins (both deep and lateral) for melanomas on the head, neck, hands, feet, genitals, or pretibial leg (26%, 8/31) versus those on the trunk and proximal extremities (54%, 54/100). The increased risk for upstaging, whatever the method of biopsy, adds to the well-documented challenges of positive margins [30] [31] [32] [33] and local recurrence 16, [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] after wide local excision of melanomas on the head, neck, hands, feet, genitals, or pretibial leg.
An explanation for the significance of the risk factors old age (OR 1.03, 95% CI 1.01-1.06, P = .002) and non-LM histopathologic subtype (OR 0.28, 95% CI 0.12-0.64, P = .002) is unclear. More severe background actinic damage with older age might increase the difficulty of discerning the most aggressive portion of a melanocytic tumor by clinical examination. LM melanomas might be more likely to have a more uniform Breslow depth compared with other histologic subtypes, but these explanations remain purely speculative and merit further study.
Of the 52/1332 (3.9%) upstaged melanomas in our cohort, 62% (32/52) warranted wider recommended surgical margins than those for the pre-excision tumor stage, and 21% (11/52) become candidates for SLNB. For melanomas at high risk for upstaging, delaying reconstruction until after histopathologic evaluation of the excisional specimen might be prudent to ensure that appropriate surgical margins are excised before definitive reconstruction. Delaying reconstruction with local flaps or skin grafts might also be judicious because the validity of SLNB after these reconstructions remains uncertain. 12, 22, 23 Patients at high risk for upstaging might also benefit from preoperative counseling about alternative surgical approaches, such as undergoing a complete excisional biopsy before definitive excision and reconstruction or Mohs surgery with frozen-section bread loaf sectioning of the debulking specimen, which permits accurate and timely identification of upstaging before tissue rearrangement. 6 Limitations of our study include the single-center, retrospective nature of our cohort. Our data are from a tertiary academic center, where patients often receive SLNB, which likely has a skewed sample with more invasive melanomas compared with the general population. The observed frequency of excisional biopsy in our cohort was 10%, which might not reflect the percentages seen at other institutions or in other regions. We were unable to assess the presence or absence of clinically visible residual lesions before excision or the percentage of the clinically visible lesions that was sampled with the diagnostic biopsies. Finally, there exists inherent variability in the microscopic tumor staging of melanoma given that frequency of discordance between expert pathologists regarding the diagnostic and prognostic attributes of melanocytic lesions. 47, 48 Identifying patients at high risk for upstaging is important to improve preoperative counseling about prognosis and surgical management. The 2 greatest risk factors for upstaging of melanomas were location on the head, neck, hands, feet, genitals, or pretibial leg and subtotal diagnostic biopsies. Patients with melanomas at high risk for upstaging might benefit from preoperative counseling that prognosis and surgical management might change after complete microscopic tumor staging. 12  12  2  T1b  3  3  0  T4b  1  1  1  T1a  T1b  3  0  2  T2a  4  0  2  T4a  1  1  1  T1b  T2a  7  0  2  T3a  3  3  1  T2a  T2b  2 
